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Abstract
Background Previous research documents suboptimal pre-
operative or postoperative care for patients undergoing
surgery. However, few existing quality measures directly
address the fundamental element of surgical care: intra-
operative care processes. This study sought to develop
quality measures for intraoperative, preoperative, and
postoperative care for carpal tunnel surgery, a common
operation in the USA.
Methods We applied a variation of the well-established
RAND/UCLA Appropriateness Method. Adherence to
measures developed using this method has been associ-
ated with improved patient outcomes in several studies.
Hand surgeons and quality measurement experts devel-
oped draft measures using guidelines and literature.
Subsequently, in a two-round modified-Delphi process,
a multidisciplinary panel of 11 national experts in carpal
tunnel syndrome (including six surgeons) reviewed
structured summaries of the evidence and rated the
measures for validity (association with improved patient
outcomes) and feasibility (ability to be assessed using
medical records).
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DOI 10.1007/s11552-011-9325-9Results Of 25 draft measures, panelists judged 22 (88%) to
be valid and feasible. Nine intraoperative measures
addressed the location and extent of surgical dissection,
release after wrist trauma, endoscopic release, and four
procedures sometimes performed during carpal tunnel
surgery. Eleven measures covered preoperative and postop-
erative evaluation and management.
Conclusions We have developed several measures that
experts, including surgeons, believe to reflect the quality
of care processes occurring during carpal tunnel surgery
and be assessable using medical records. Although quality
measures like these cannot assess a surgeon’s skill in
handling the instruments, they can assess many important
aspects of intraoperative care. Intraoperative measures
should be developed for other procedures.
Keywords Carpal tunnel syndrome.Health care quality
assurance.Standards.Surgery
Payers, policymakers, and surgeons are paying increasing
attention to the quality of the surgical care provided in the
USA. Better surgical care increases the likelihood that
patients will experience favorable outcomes and be free
of complications. From a societal standpoint, this may
yield economic benefits by reducing disability and
avoiding the medical care costs associated with compli-
cations. Consequently, efforts to measure and improve
the quality of surgical care are becoming more wide-
spread. The Surgical Care Improvement Project now sets
national standards for process measures such as prophy-
lactic antibiotics, prophylaxis against deep venous
thrombosis, use of preoperative beta-blockers, and pre-
vention of ventilator-associated pneumonia [12]. The
high cost attributed to complications has convinced a
number of insurance companies to subsidize surgeons’
e f f o r t st om o n i t o ra n di m p r o v eq u a l i t y[ 5]. Similarly,
Medicare has experimented with pay-for-performance
incentives for physicians [12]. In the future, these national
efforts to evaluate surgical quality of care are likely to
expand.
To measure the quality of surgical care, specific
measures are needed. Process-oriented measures identify
care processes that patients should or should not receive
under specified circumstances. The purpose of such
measures is to make existing standards of care explicit
and measurable. Generally, quality measures delineate basic
standards of care, in contrast to guidelines, which describe
both minimum standards and best practices [26].
Most process measures pertaining to surgical procedures
address the appropriateness of surgery (i.e., whether the
surgery should be performed or not), preoperative care, or
postoperative care. Very few existing measures address the
fundamental element of surgical care: care during an
operation. Yet good intraoperative care is critical to
achieving favorable surgical outcomes. Some important
aspects of intraoperative care are challenging to measure,
such as the surgeon’s dexterity in using the instruments or
handling tissues. Nevertheless, other important aspects of
intraoperative care can be assessed by reviewing operative
reports and related records.
Our objective in this study was to develop a set of
quality measures that can be used to assess, via medical
record review, key aspects of intraoperative care as well
as preoperative and postoperative care provided to
patients undergoing carpal tunnel surgery. We chose to
focus on carpal tunnel release surgery for two reasons.
First, carpal tunnel syndrome causes substantial disability
among working-age adults, which means that improving
patient outcomes is likely to benefit both the affected
individuals, through reduced symptoms, and their
employers, through reduced absenteeism, improved pro-
ductivity at work, and reduced healthcare expenditures
[6]. Second, studies suggest that the outcomes of carpal
tunnel surgery are not always optimal, with unsatisfactory
results occurring in up to 10–15% of patients [1, 8, 13,
14]. Some variability in outcomes appears attributable to
patient characteristics [1, 11]. However, some poor out-
comes may be due to patients receiving less than optimal
surgical care.
Quality measures should be based on high-quality
studies whenever possible. However, randomized con-
trolled trials do not exist for most healthcare processes,
particularly many aspects of surgical care including
intraoperative processes [2, 25]. We, therefore, developed
these measures using a variation of the RAND/UCLA
Appropriateness Method. A particular strength of this
method is its ability to consider available evidence and
overcome important gaps by rigorously synthesizing the
experience of expert clinicians [7]. Syntheses of clinical
expertise are a valid and important form of evidence, as
demonstrated by the fact that better adherence to
measures developed using this method have been associ-
ated with improved patient outcomes in multiple studies.
For example, judgments about the appropriateness of
carotid endarterectomy were consistent with the findings
of a subsequent randomized trial [9, 10, 22]. For
arthroplasty of the knee and hip, judgments about the
appropriateness of surgery were associated with improved
quality of life [20].
Materials and Methods
Quality measure development follows a three-step process:
(1) creating draft measures by integrating guidelines and
literature, (2) refining and selecting final measures, and (3)
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on the first two steps and the results of early pilot testing.
This was one aspect of an effort to develop quality
measures for carpal tunnel syndrome; other measures have
been reported separately [16, 17, 21].
Developing Draft Measures
Developing draft measures was an iterative process involv-
ing collaboration among two hand surgeons, one general
surgeon with experience developing measures of surgical
quality, and two internists with expertise in quality
measurement. First, we conducted a general literature
search on carpal tunnel syndrome, searched MEDLINE,
National Guidelines Clearinghouse, specialty society web-
sites, and other sources of publicly available guidelines, and
accessed personal reference collections. Team hand sur-
geons reviewed the guidelines and literature, chose key
intraoperative and perioperative care processes that are
likely to affect patient outcomes or that are widely
recommended, then wrote draft measures.
Directed MEDLINE searches were conducted to identify
evidence pertinent to the draft measures (search terms:
surgery for carpal tunnel syndrome OR median neuropathy,
additional MeSH terms used: surgical procedures, opera-
tive). For 845 citations identified, hand surgeons sequen-
tially reviewed titles, abstracts, and articles to assess
relevance to each draft measure. Draft measures were then
refined, added, and deleted.
Next, the hand surgeons summarized, for each draft
measure, the evidence supporting the relationship between
the care process and patient outcomes, emphasizing the
highest quality evidence identified. Given most evidence
was not high quality, they used a simplified classification
scheme: level 1, randomized controlled trial; 2, observa-
tional study; and 3, case series and expert opinion. Where
level 1 evidence was not available, the summary described
a chain of evidence or clinical rationale, including
recommendations from recent guidelines.
Refining and Selecting Measures
Methods for refining and selecting quality measures were
derived from the RAND/UCLA Appropriateness Method, a
multidisciplinary, two-round, modified-Delphi process that
enables researchers to obtain a quantitative assessment that
reflects the judgment of a group of experts [7]. This well-
established method (described below) has been used to
develop quality measures for surgical care and determine the
appropriateness of many surgical procedures. The method has
reproducibility consistent with that of well-accepted diagnostic
tests like screening mammography—i.e., separate panels
examining the same topic have produced similar recommen-
dations (kappas 0.51–0.83) [15, 23]. Further, the measures
developed using this method have been shown to have
content, construct, and predictive validity, as evidenced by the
association between adherence to the measures and improved
patient outcomes in multiple studies. Additional details about
this method have been published previously [7, 22].
For this study, we selected a panel with 11 members:
four hand surgeons, two orthopedists, an occupational
medicine physician, a neurologist, a physiatrist, a family
physician, and a physical therapist. Including a variety of
clinical backgrounds is essential to the RAND/UCLA panel
process because it increases the range of issues that the
panel considers and discusses. National specialty societies
recommended leaders in each specialty, and then we
selected panelists representing a variety of geographic
locations, expertise, and practice settings. Several surgeons
were involved in the guideline development effort by the
American Academy of Orthopedic Surgery (AAOS) [3, 4].
The first round ofratingsinvolved having panelists rate the
measuresathome.Panelistsreceivedtheevidencesummaries,
draft measures, ballots, and instructions. During the second
round, panelists met in person and research team members
moderated discussions of each draft measure, the evidence,
and first-round ratings. This panel method allows different
attitudes to be expressed and contend with one another in
order toallowtrueagreement ordisagreementtoemerge.This
is in contrast to a consensus–panel method, which typically
forces the group to reach agreement. Panelists suggested
modifications to definitions of key terms and measures; these
were adopted when a majority voted to do so. After all
opinions had been voiced for a measure, all panelists marked
private, equally weighted ballots.
For both rounds, panelists rated validity, feasibility, and
importance on 9-point scales (9=highest). Validity meant:
(1) adequate scientific evidence or professional consensus
exists to support a link between the performance of care
specified by the measure and improved clinical outcomes;
and (2) based on the panelists’ professional experience,
health professionals with significantly higher rates of
adherence to a measure would be considered higher-
quality providers. Panelists were also instructed that, for a
measure to be valid, both the care itself and the documen-
tation of that care in the medical record must be important
reflections of quality. Following standard procedures for
this panel method, we interpreted validity ratings as
follows: valid=median of 7–9 without disagreement; not
valid=median of 1–3 without disagreement; uncertain
validity=median of 4–6, or any median with disagreement.
Disagreement was defined as three or more panelists rating
in the 1–3 range and three or more in the 7–9 range [7].
We also included feasibility and importance to enable
future users to prioritize the measures. Feasibility meant the
potential ability to evaluate adherence to the measure using
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care provided. Measures were considered infeasible if the
median rating was below 4. Importance meant the magni-
tude of the potential effect on patient outcomes; there was
no minimum threshold for importance.
Pilot Testing
After identifying measures meeting the validity and
feasibility criteria, RAND staff developed a detailed tool
for scoring them and pilot tested the measures and tool in a
large workers’ compensation provider organization (Kaiser
Permanente Northern California Regional Occupational
Health) and in a large workers’ compensation insurance
company (the California State Compensation Insurance
Fund) [18]. Six nurses and one physical therapist, who
routinely perform claims reviews within each organization,
underwent a 2-day training in the use of the tool and scored
several practice cases. Finally, they reviewed records for
28 patients who had been diagnosed with carpal tunnel
syndrome (CTS) or conditions often confused with CTS.
During the training and pilot testing, these abstractors
provided feedback on the tool. The pilot test activities were
approved by each of the institutional human subjects’
protection committees; informed consent was not required.
Results
Panel Evaluation of Measures
We developed 24 draft measures and the panel made changes
to all but two of them, including splitting one measure into
two. Two intraoperative measures did not meet validity
criteria. Panelists deleted one postoperative measure because
it addressed a rare situation. The 22 remaining measures
(88%) met the validity and feasibility criteria. For the intra-
operative and perioperative measures, respectively, Tables 1
and 2 list the measures themselves. Tables 3 and 4 list
median ratings for validity, feasibility, importance, and the
highest level of supporting evidence.
The Appendix provides the rationale for each passing
measure, including a summary of the relevant literature. For
few, if any, of these measures was there a large randomized
Table 1 Intraoperative care measures meeting validity and feasibility criteria
# Measure
1 Indications for primary open rather than endoscopic release
If a carpal tunnel release procedure is performed and the patient has a suspected mass lesion or one documented by MRI/CT or ultrasound within the
carpal tunnel (e.g., ganglion cyst), severe rheumatoid arthritis, or severe tenosynovitis of the wrist in the medical record, then the release shouldb e
performed open rather than endoscopically
2 Prompt release in wrist injury
If a patient has signs and/or symptoms of carpal tunnel syndrome following a distal radius fracture or other severe wrist injury and those symptoms
worsen with closed reduction of the fracture or immobilization of the wrist injury, then carpal tunnel release surgery should be offered within 48 h
3 Documentation of proximal transverse incision location in endoscopic release
If a patient undergoes endoscopic carpal tunnel release surgery, then there must be documentation in the operative report that the proximal transverse
incision was ulnar to the palmaris longus or did not extend radial to the radial aspect of ring finger if the palmaris longus is absent
4 Documentation that deep surface of transverse carpal ligament was identified in endoscopic release
If a patient undergoes endoscopic carpal tunnel release surgery, then there should be documentation in the operative report that the deep surface of the
transverse carpal ligament was identified prior to transection
5 Documentation of transverse carpal ligament release
If a patient undergoes carpal tunnel release surgery, then there must be documentation in the operative report that the transverse carpal ligament was
released
6 Limit superficial epineurotomy to specific indications
If a patient undergoes primary open carpal tunnel release surgery, then superficial epineurotomy should not be performed unless specific injury or
scarring of the median nerve was present
7 Limit internal neurolysis to specific indications
If a patient undergoes open carpal tunnel release surgery, then internal neurolysis should not be performed unless specific injury or scarring of the
median nerve was present
8 Limit flexor tenosynovectomy to specific indications
If a patient undergoes carpal tunnel release surgery and does not have concomitant severe proliferative tenosynovitis (e.g., gout, inflammatory arthritis,
or infection), then a flexor tenosynovectomy should not be performed
9 Avoidance of routine transverse carpal ligament repair
If a patient undergoes open carpal tunnel release surgery, then the transverse carpal ligament should not be repaired
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# Measure
10 Recent preoperative visit with surgical team
If a patient undergoes carpal tunnel release surgery, then there must be documentation of a visit between the operating surgeon (or member of the
operating team) and patient within 1 month prior to the date of surgery
11 Required elements of general preoperative history
If a patient undergoes carpal tunnel release surgery, then there must exist a detailed general medical history (or an update of a previously taken
history specifying any changes or lack thereof) updated within 1 month prior to surgery including
(a) medical co-morbidities
(b) past surgical history
(c) medications
(d) “allergies” (medication intolerances)
(e) general review of systems including at least two organ systems
12 Required elements of CTS-specific preoperative evaluation
If a patient undergoes carpal tunnel release surgery, then there must be documentation by the operating surgeon (or member of the surgical team)
specifically noting all three of the following
(1) Presence or absence of paresthesias and/or pain in median-nerve distribution,
(2) Physical examination findings including presence or absence weakness of median-nerve- innervated muscles and/or thenar atrophy,
(3) Discussion of whether electrodiagnostic testing was performed and any results
13 Adequate documentation of any prior treatments for carpal tunnel syndrome
If a patient undergoes carpal tunnel release surgery, then there must be documentation by operating surgeon (or member of the operating team)
specifically noting the presence or absence of history of previous treatments for carpal tunnel syndrome
14 Preoperative electrodiagnostic testing for work-associated carpal tunnel syndrome
If patient undergoes carpal tunnel release surgery and has carpal tunnel syndrome thought to be associated with their occupation, then the patient
should undergo preoperative electrodiagnostic testing
15 Preoperative evaluation of any suspected cervical radiculopathy
If a patient has carpal tunnel syndrome and any suspected cervical radiculopathy, then carpal tunnel release surgery should not be performed before
the patient has been evaluated further with one or more of the following
(1) EMG/NCS looking for radiculopathy,
(2) cervical spine radiographs or MRI, or
(3) referral to neurology, neurosurgery, or physical medicine
16 Consent for open procedure in planned endoscopic release
If a patient undergoes an attempt at endoscopic carpal tunnel release surgery, then the patient should have been consented for possible open procedure
17 Requirement for at least one postoperative visit
If a patient undergoes carpal tunnel surgery, then they must be seen by a medical provider or physical/occupational/hand therapist for a postoperative
clinic appointment within the first 2 weeks
18 Required elements of any postoperative evaluation by surgical team
If a patient undergoes carpal tunnel surgery and has one or more postoperative appointments with the surgical team, then, at the first such visit, a
surgical team member should evaluate the current carpal tunnel-related symptoms because the response to surgery and the presence or absence of
complications should be assessed so that problems can be identified and treated
19 Monitoring of any postoperative stiffness
If a patient undergoes a carpal tunnel release and has finger stiffness postoperatively at 2 weeks, then they must be reevaluated within 2 weeks by the
operative team
20 Management of any postoperative stiffness
If a patient undergoes a carpal tunnel release and has finger stiffness postoperatively at 6 weeks, then they must be referred for physical/occupational/
hand therapy
21 Monitoring of any lack of improvement
If a patient undergoes a carpal tunnel release and does not experience significant improvement in symptoms during the first 3 months following
surgery, then the surgeon should personally reexamine the patient at least one additional visit
22 Required elements of evaluation of any lack of improvement
If a patient undergoes carpal tunnel release surgery and does not experience significant improvement in symptoms after surgery, then the patient
should be evaluated for reasons for lack of improvement (unless the patient refuses) via at least one of the following performed within 1 year
postoperatively
(1) ordering one or more diagnostic tests, or
(2) referring the patient to another specialist for a second opinion
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examining the effect of the care described. Nevertheless, in
each instance, there is convincing chain of evidence or
clinical rationale that supports the practice.
Pilot Testing
Of 28 patients in the pilot study, 14 had CTS and
underwent carpal tunnel surgery for the first time during
the study period; one additional patient had undergone
surgery in the past.
After reviewing the operative reports for the intraoperative
measures, the abstractors reported that several measures were
challenging to score because the reports used unusual and
highlyvariabletermstodescribetheoperations.Toinvestigate
these concerns, a general internal medicine physician
performedspotimplicitreviewsofoperativereports,observed
the substantial variability in terminology, and concluded that
individuals with specific training or experience writing or
reviewing these types of operative reports would be required
to score the intraoperative measures. The seven abstractors
reported no feasibility concerns for the pre- and postoperative
care measures.
Discussion
We have developed nine measures that can be used to
assess the quality of the intraoperative care provided to
patients undergoing carpal tunnel surgery, as well as 11
measures pertaining to pre- and postoperative care. A
multidisciplinary panel of national experts in carpal tunnel
syndrome, including several hand surgeons and orthoped-
ists, rated these measures as valid reflections of quality and
feasible for use with medical record review.
The preoperative measures are generally intended to
ensure that surgeons are able to make an accurate diagnosis
and adequately assess the potential risks and benefits of
carpal tunnel surgery. Because an incorrect diagnosis is a
common reason that patients do not improve after carpal
tunnel surgery, these preoperative measures are likely to
reduce unnecessary and inappropriate operations [24]. In
contrast, the intraoperative measures are designed to reduce
the risks of serious surgical complications and persistent
CTS symptoms. Damage to the median nerve (or its palmar
cutaneous branch) is a particularly severe and disabling
complication that several measures (#1, 3, 4, and 6–9) are
designed to prevent. The remaining intraoperative measures
(#2 and 5) are intended to reduce the chance that symptoms
will not improve after surgery, also a fairly common
occurrence [24]. Several of the postoperative measures
assess whether providers identify and respond to these
types of problems appropriately.
We know of very few other existing quality measures
that focus on the quality of intraoperative care processes,
regardless of the type of procedure. Assessing surgical
appropriateness or outcomes is far more common. For
example, a 2006 systematic review of quality measures for
Table 3 Panelists’ ratings and evidence level for intraoperative care measures
Measure title Validity Feasibility Importance Evidence
Median
a
(range)
N (%) of
ratings ≥7
Median
b
(range)
N (%) of
ratings ≥4
Median
(range)
Level
c
1. Indications for primary open rather than endoscopic release 8 (7–9) 11 (100) 8 (7–9) 11 (100) 8 (7–9) 3
2. Prompt release in wrist injury 7 (7–8) 11 (100) 7 (5–9) 11 (100) 8 (7–9) 3
3. Documentation of proximal transverse incision location in
endoscopic release
7( 5 –9) 8 (73) 6 (2–9) 10 (91) 7 (3–9) 3
4. Documentation that deep surface of transverse carpal ligament
was identified in endoscopic release
7( 5 –9) 10 (91) 7 (1–9) 9 (82) 7 (1–9) 3
5. Documentation of transverse carpal ligament release 8 (7–9) 11 (100) 5 (1–9) 9 (82) 8 (1–9) 3
6. Limit superficial epineurotomy to specific indications 7 (6–9) 10 (91) 8 (6–9) 11 (100) 8 (5–9) 1
7. Limit internal neurolysis to specific indications 8 (7–9) 11 (100) 8 (7–9) 11 (100) 8 (7–9) 1
8. Limit flexor tenosynovectomy to specific indications 7 (7–9) 11 (100) 8 (7–9) 11 (100) 8 (7–9) 1
9. Avoidance of routine transverse carpal ligament repair 7 (6–9) 10 (91) 8 (6–9) 11 (100) 8 (5–9) 3
Measures that did not meet validity criteria
Documentation of distal forearm fascia release 5 (3–7) 4 (36) 5 (1–9) 8 (73) 5 (1–8) N/A
Release of any concomitant proximal compression in the forearm 2 (1–7) 2 (18) 2 (1–7) 4 (36) 2 (1–7) N/A
aRatings ≥7 indicated panelists thought the measure was valid
bRatings ≥4 indicated panelists thought the measure was potentially feasible
cLevel of evidence: 1 randomized controlled trial, 2 observational data, 3 case series or expert consensus
124 HAND (2011) 6:119–131colon cancer identified several that assess the appropriate-
ness of surgery, the type of procedure chosen, recurrence
rates, complication rates, and mortality rates. None of the
measures addressed specific intraoperative care processes
[19].
The reason for this dearth in process measures for
intraoperative care is unclear but it could relate to
concerns about feasibility. Certainly, there are many
critical aspects of the art of surgery that cannot be
assessed by reviewing medical records, such as a
surgeon’s dexterity or meticulousness in achieving
hemostasis. Nevertheless, operations are comprised of
individual steps that surgeons can choose to perform or
forgo, the purpose of operative reports is to document
the steps taken, and the steps taken or foregone
influence patient outcomes. For example, the number
of lymph nodes harvested during the resection of colon
cancer has been shown to influence the likelihood of
recurrence [19]. The intraoperative measures, we devel-
oped comprise discrete individual steps in the performance
of carpal tunnel surgery. Each of these steps is, in the
opinions of our national experts, likely to influence
specific patient outcomes, for reasons outlined above and
explained in detail in the Appendix.F u r t h e r ,t h ep a n e l i s t s
believed that documenting each of these steps in the
medical record was essential to providing adequate quality
surgical care.
The ultimate test of quality measures’ feasibility
involves applying them to medical records, and here we
must acknowledge that our work to date is incomplete. Pilot
testing the intraoperative measures enabled us to determine
that nurses and general internists can have difficulty scoring
Table 4 Panelists’ ratings and evidence level for preoperative and postoperative quality measures
Measure Validity Feasibility Importance Evidence
Median
a
(range)
N (%) of
ratings ≥7
Median
b
(range)
N (%) of
ratings ≥4
Median
(range)
Level
c
Preoperative care
10. Recent preoperative visit with surgical team 7 (2–9) 8 (73) 8 (3–9) 10 (91) 7 (2–9) 3
11. Required elements of general preoperative history
(a) Medical co-morbidities 8 (7–9) 11 (100) 8 (7–9) 11 (100) 8 (6–9) 3
(b) Past surgical history 7 (3–9) 6 (55) 8 (4–9) 11 (100) 6 (3–8) 3
(c) Medications 7 (4–9) 10 (91) 8 (6–9) 11 (100) 7 (5–9) 3
(d) “Allergies” (medication intolerances) 7 (4–9) 8 (73) 8 (6–9) 11 (100) 8 (4–9) 3
(e) General review of systems including at least two organ systems 7 (3–9) 8 (73) 8 (6–9) 11 (100) 7 (3–8) 3
12. Required elements of CTS-specific preoperative evaluation 9 (7–9) 11 (100) 9 (7–9) 11 (100) 9 (7–9) 2 and 3
13. Adequate documentation of any prior treatments for carpal
tunnel syndrome
8( 6 –8) 8 (73) 8 (6–9) 11 (100) 8 (6–9) 2 and 3
14. Preoperative electrodiagnostic testing for work-associated
carpal tunnel syndrome
9( 4 –9) 10 (91) 9 (6–9) 11 (100) 9 (7–9) 2 and 3
15. Preoperative evaluation of any suspected cervical radiculopathy 7 (5–9) 8 (73) 7 (5–9) 11 (100) 8 (5–9) 3
16. Consent for open procedure in planned endoscopic release 7 (6–9) 10 (91) 8 (7–9) 11 (100) 7 (5–9) 2
Postoperative care
17. Requirement for at least one postoperative visit 8 (7–9) 11 (100) 8 (6–9) 11 (100) 8 (6–9) 2
18. Required elements of any postoperative evaluation by surgical team 8 (7–9) 11 (100) 8 (7–9) 11 (100) 8 (7–9) 3
19. Monitoring of any postoperative stiffness 7 (6–9) 9 (82) 8 (6–9) 11 (100) 8 (5–9) 3
20. Management of any postoperative stiffness 7 (5–9) 9 (82) 8 (5–9) 11 (100) 8 (5–9) 3
21. Monitoring of any lack of improvement 7 (7–9) 11 (100) 8 (7–9) 11 (100) 8 (6–9) 3
22. Required elements of evaluation of any lack of improvement 7 (6–9) 10 (91) 8 (6–9) 11 (100) 7 (5–9) 3
Measure deleted by panelists due to low frequency of occurrence
Evaluation of any new weakness or numbness developing
postoperatively
N/A
d N/A N/A N/A
aRatings ≥7 indicated panelists thought the measure was valid
bRatings ≥4 indicated panelists thought the measure was potentially feasible
cLevel of evidence: 1 randomized controlled trial, 2 observational data, 3 case series or expert consensus
dN/A not applicable
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dures using unusual or variable terms. Our panelists, who
included several surgeons, were generally very confident
that the measures would be feasible, as evidenced by the
fact that median feasibility scores were 7 or higher for
seven of the nine intraoperative measures. Future work will
need to confirm the feasibility of these measures by having
surgeons who operate on the hand, or perhaps specially
trained nurses, score them. If the intraoperative measures
must be scored by surgeons rather than nurses, this will
increase the cost of assessing quality of care. However,
operative reports are concise documents that are relatively
easy to obtain and review.
We are also planning future work to confirm the validity
of the measures we have developed. For quality measures,
the ultimate test of validity entails assessing whether better
adherence is associated with better patient outcomes.
However, most quality measures in wide use today have
yet to be tested in this manner. We have developed a project
that would compare adherence to these measures with
patients’ clinical outcomes as well as assess the relationship
between quality, outcomes, and the costs of care and
disability due to CTS.
Once the feasibility and validity of these measures has
been confirmed, there are several ways that they could be
used. Individual surgeons can use these measures to
evaluate the quality of the care they provide. In some
fields, board recertification is now contingent upon pro-
viders engaging in such activities. Practices with multiple
surgeons can evaluate quality for the practice and, if
warranted, develop an infrastructure that supports improve-
ment. Such organizational efforts are particularly likely to
be effective because they leverage the contributions of
many individuals, and enable systems to be established that
make adherence simpler. Payers might consider using these
measures as a basis for referring patients to higher-quality
providers, or as a basis for offering higher-quality providers
greater remuneration. Because it is easier for payers to
obtain and review operative reports than the entire medical
record, the payers may find the intraoperative measures
more feasible than the pre- and postoperative ones, which
will require access to clinic notes. Finally, researchers can
identify factors associated with better quality.
For the purposes of improving care, quality measures are
most useful when they address basic standards of care that
have not already been widely implemented. We suspect that
baseline rates of adherence will be higher for some of these
measures than for others. For example, because Medicare
and other payers require histories and physical examina-
tions to include specific elements, we suspect that the
stipulations of measure #11 will usually be met. In contrast,
we expect that the incision location and release of the
transverse carpal ligament (measures #3 and 4) may not be
documented consistently. Future research will be needed to
confirm or refute these hypotheses.
These measures also have other limitations. As noted,
not all important aspects of care for patients undergoing
carpal tunnel surgery are amenable to direct measurement.
Further, unique clinical circumstances can warrant excep-
tions to a measure. Justifiable exceptions are not problem-
atic so long as they are rare and randomly distributed
among populations of patients. The literature examining
these practices is rather limited, and most of the measures
are based on expert consensus. In contrast to some fields,
such as cardiology, both musculoskeletal disorders and
surgical care suffer for a lack of large, high-quality
randomized controlled trials. Trials are not possible for all
important care processes, however. For example, it would
be unethical to randomly assign an incision location that
can damage to the palmar cutaneous branch of the median
nerve. The panel method we used offers a rigorous and
ethically acceptable approach to determining the right care
in such clinical situations.
In conclusion, this project has developed a set of
measures that can be used to evaluate the quality of the
care provided to populations of patients undergoing carpal
tunnel surgery. The several measures focusing on intra-
operative care processes represent an important advance in
the science of measuring quality of care. These measures
will be useful in efforts to improve quality of care for
patients with carpal tunnel syndrome, whether initiated by
providers, medical groups, payers, or policymakers. Intra-
operative measures should be developed for other common
operations.
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Appendix
Intraoperative Care Measures Meeting Validity
and Feasibility Criteria
1. Indications for Primary Open Rather Than Endoscopic
Release: Panelists identified two compelling indications
for performing carpal tunnel surgery open: (1) a mass
lesion in the canal, and (2) severe proliferative
tenosynovitis. These conditions can impair endoscopic
visualization of the undersurface of the transverse
carpal ligament, which is critical to avoiding uninten-
tional nerve injury. Mass lesions can include bone
spurs, ganglion cysts, etc.,
1 and may be suspected
clinically or on imaging. Patients with severe rheuma-
toid arthritis are at risk for having tenosynovitis.
2. Prompt Release in Wrist Injury: Swelling or hematoma
formation within or near the median nerve can lead to
carpal tunnel symptoms, as can displaced bone from a
fracture.
2 If unrelieved, this can lead to permanent
nerve injury. The panelists concluded that it is
necessary to perform carpal tunnel surgery urgently
when carpal tunnel symptoms develop following a
severe wrist injury and persist despite treatment of the
injury.
3. Documentation of Proximal Transverse Incision Loca-
tion in Endoscopic Release: For endoscopic carpal
tunnel surgery, a transverse incision crossing radial to
the palmaris longus tendon is a common cause of injury
to the palmar cutaneous branch of the median nerve.
3
Placing the incision ulnar to the palmaris longus tendon
(or, if the palmaris longus is absent, radial to the radial
aspect of the ring finger) reduces this risk. Panelists felt
that documenting the incision’s location is important.
For example, such documentation is helpful when
patients present postoperatively with new pain, tender-
ness, or numbness.
4. Documentation that Deep Surface of Transverse
Carpal Ligament was Identified in Endoscopic
Release: During endoscopic carpal tunnel surgery,
attempting to transect the transverse carpal ligament
without visualizing its deep surface increases the
risk of damaging adjacent structures, including the
median nerve.
4–6 Extra-bursal endoscopic carpal
tunnel surgery with direct visualization of the trans-
verse carpal ligament led to fewer complications in a
multicenter study comparing the extra-bursal two-
incision Chow technique with intra-bursal release.
4
Panelists believed that documentation that the trans-
verse carpal ligament was visualized is important. For
example, such documentation is helpful when present
postoperatively with numbness or weakness in the
median-nerve distribution.
5. Documentation of Transverse Carpal Ligament Release:
Incompletereleaseofthetransversecarpalligamentisone
of the more common complications of carpal tunnel
surgery
7–10 and the most common reason that symptoms
fail to improve.
11 Panelists believed that documentation
that the transverse carpal ligament was, in fact, released,
therefore, was essential in case patients’symptoms fail to
improve postoperatively.
6. Limit Superficial Epineurotomy to Specific Indications:
Microscopic epineural scarring or fibrosis was once
hypothesized to contribute to carpal tunnel syndrome,
leading some surgeons to routinely perform epineur-
otomy with open carpal tunnel surgery. However, level
1 evidence from multiple studies indicates that this
practice is of no benefit,
12–14 and the additional
manipulation of the nerve may increase the risk of
injury. Consequently, panelists concluded that epineur-
otomy is inappropriate unless scarring of the median
nerve (or another injury) is present.
7. Limit Internal Neurolysis to Specific Indications:
Routine internal neurolysis was once advocated for
similar reasons as epineurotomy.
15 Subsequently, level
1 evidence from multiple studies has demonstrated no
benefit.
16–19 Because internal neurolysis requires a
more extensive dissection using a microscope and
micro-instruments, it may increase the risk of nerve
injury and peri-neural scarring.
10 The panelists believed
that, in the absence of a specific indication, such as
injury or scarring of the nerve, performing internal
neurolysis is inappropriate.
8. Limit Flexor Tenosynovectomy to Specific Indications:
Performing tenosynovectomy is unproven but generally
accepted for conditions that cause tenosynovitis, such
as gout, rheumatoid arthritis and diabetes mellitus.
Tenosynovitis can cause recurrent carpal tunnel syn-
drome,
20,
21 and tenosynovectomy may prevent this.
22
However, in a prospective trial addressing the utility of
routine tenosynovectomy in 87 patients undergoing
carpal tunnel surgery, no benefit was observed.
23
Further, the additional dissection increases the risk of
nerve injury or scarring. The panelists concluded that
tenosynovectomy is inappropriate in the absence of
documented tenosynovitis or the conditions associated
with it.
9. Avoidance of Routine Transverse Carpal Ligament
Repair: Reconstructing the transverse carpal ligament
following transection has been hypothesized to prevent
HAND (2011) 6:119–131 127postoperative “bowstringing” of the flexor tendons
(bulging toward the volar surface of the wrist), improve
grip strength,
24,
25 protect the median nerve, and
preserve nerve gliding.
26 One small non-randomized
prospective study with short-term follow-up demon-
strated increased grip strength in the group with
transverse carpal ligament repair compared with a
control group.
27 However, transverse carpal ligament
repair requires extensive dissection and release of
Guyon’s canal with mobilization of the ulnar nerve
and artery, which may increase the risk of complica-
tions, including recurrent carpal tunnel syndrome.
8
Flexor tendon bowstringing is an uncommon compli-
cation
28 and, if it does occur, the transverse carpal
ligament can be reconstructed with a free tendon graft.
7
Therefore, the panelists concluded that routine trans-
verse carpal ligament repair is inappropriate.
Rationale for Preoperative Care Measures
10. Recent Preoperative Visit With Surgical Team: Panel-
ists believed that it is necessary for the operative team
to evaluate a patient shortly before carpal tunnel
surgery because co-morbid conditions, symptoms and
signs can change over time and influence the
appropriateness of surgery as well as the appropriate
operative approach.
11. Required Elements of General Preoperative History:
The panel believed that a recent, detailed preoperative
history can influence perioperative management as
well as outcomes. Co-existent medical conditions,
particularly rheumatoid arthritis and diabetes are
common among carpal tunnel syndrome patients.
29,
30
Rheumatoid arthritis can influence the operative
technique (see below), and hyperglycemia may
influence operative outcomes.
31 Current medication
lists, medication intolerances (“allergies”), past sur-
gical history, and a review of systems can influence
the selection of anesthesia and pain medications as
well as the operative approach. A general history can
be obtained by providers other than the hand
surgeon.
12. Required Elements of CTS-Specific Preoperative
Evaluation: Documenting carpal tunnel symptoms,
signs, and the results of electrodiagnostic testing
before carpal tunnel surgery is necessary for the
surgical team to do because there is no single
method for confirming carpal tunnel syndrome,
32,
33
and an incorrect diagnosis is a common reason for lack
of improvement after carpal tunnel surgery.
11 On the
basis of a meta-regression analysis, the AAOS guide-
line concluded that clinical and electrodiagnostic tests
together, but neither alone, were significantly associated
with positive surgical outcomes.
34 An earlier systematic
review comparing symptoms and signs against electro-
diagnostic test results concluded that classic or high
probability symptoms on a Katz hand diagram,
weakness on thumb abduction strength testing, and
hypalgesia of second digit adequately distinguish carpal
tunnel syndrome from other conditions.
32 Other studies
have found that thenar atrophy is associated with a
lower likelihood of symptom resolution following
carpal tunnel surgery.
35,
36 The current panel felt that
a basic standard of care involves documenting the
presence or absence symptoms in the median-nerve
distribution, thenar muscle weakness (whether abduc-
tion or opposition is tested) or thenar atrophy, and
electrodiagnostic test results.
13. Adequate Documentation of Any Prior Treatments for
Carpal Tunnel Syndrome: Documenting whether a
patient has undergone any previous carpal tunnel
syndrome treatments is necessary for the surgical
team to do because this has prognostic and therapeutic
implications. Relief of symptoms following steroid
injection into the carpal tunnel is predictive of better
results following carpal tunnel surgery.
35,
37,
38
Further, the current panel found responses to splinting,
activity modification, and steroid injection relevant to
determining whether carpal tunnel surgery is indicated
or not.
39
14. Preoperative Electrodiagnostic Testing for Work-
Associated Carpal Tunnel Syndrome: The panelists
concluded that, while preoperative electrodiagnostic
testing is generally recommended, it is essential when
carpal tunnel syndrome appears work-associated.
Many observational studies have found patients with
workers‘compensation claims have worse functional
and disability outcomes following carpal tunnel
surgery than patients without such claims.
40–46 There-
fore, a higher degree of preoperative diagnostic
certainty is required for workers’ compensation
patients.
15. Preoperative Evaluation of Any Suspected Cervical
Radiculopathy: When providers suspect that a patient
might have cervical radiculopathy in addition to or
instead of carpal tunnel syndrome, the panelists felt
that evaluating the cervical spine is necessary before
carpal tunnel surgery because undiagnosed cervical
radiculopathy is a common reason that carpal tunnel-
like symptoms persist following carpal tunnel sur-
gery.
47–50 Electrodiagnostic testing,
50 obtaining cervi-
cal spine radiographs or magnetic resonance
imaging,
51 or referring a patient to another provider
with expertise in nerve impingement syndromes can
be helpful.
128 HAND (2011) 6:119–13116. Consent for Open Procedure in Planned Endoscopic
Release: When an endoscopic carpal tunnel surgery is
planned, the panelists believed that obtaining in-
formed consent for a possible conversion to an open
approach is necessary because conversions occur in
about 2.5% of cases.
52,
53
Rationale for Postoperative Care Measures
17. Requirement for at Least One Postoperative Visit: At
least one visit with the surgical team, a medical
provider, or therapist who treats hand disorders is
necessary within 2 weeks after carpal tunnel surgery
because many patients experience treatable short-term
adverse effects. In one study, carpal tunnel surgery
patients experienced scar pain or hypertrophy (61%),
stiffness (28%), skin irritation (28%), hematoma
(11%), and infection (6%).
54 The panelists did not
believe that the postoperative visit has to be with a
hand surgeon, however, because outcomes are similar
when patients follow-up with general practitioners
(except they may over-diagnose infections).
55
18. Required Elements of Any Postoperative Evaluation
by Surgical Team: The panelists believed that doc-
umenting any change in carpal tunnel syndrome
symptoms after carpal tunnel surgery is important for
the operating team to do because these symptoms are
the principal reason for performing carpal tunnel
surgery, can worsen after surgery,
54 and warranted
evaluation if they persist.
19. Monitoring of Postoperative Stiffness: When patients
present with postoperative stiffness at early postoper-
ative visits, the panelists concluded that reevaluation
by the surgical team is necessary so that the team can
determine whether hand therapy is indicated (below).
20. Management of Postoperative Stiffness: One prospec-
tive randomized controlled study of 100 patients
undergoing carpal tunnel surgery assessed routine
postoperative hand therapy and found return to work
was faster (32 vs. 43 days, p<0.006),
56 suggesting
that hand therapy may influence functional status.
Panelists believed that patients who experience post-
operative stiffness at 6 weeks are at increased risk for
delayed recovery of functional status and that referral
for hand therapy is necessary.
21. Monitoring for Lack of Improvement: The panelists
believed that, when patients do not exhibit improve-
ment by 3 months postoperatively, it is necessary for
the surgeon to monitor them further because, if this
persists, evaluation is warranted (below).
22. Required Elements of Evaluation if Lack of Symptom-
atic Improvement: Evaluating patients who do not
exhibit improvement following carpal tunnel surgery is
necessary within 1 year, the panelists concluded. Given
the broad range of issues that may prevent symptomatic
improvement,
11 the evaluation may include a variety of
diagnostic tests or an evaluation by other providers
with relevant expertise. The evaluation should occur
within a year given that symptoms generally resolve or
plateau by 6 months.
57–60
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